AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

RIFAXIMIN 200 Mg ;

11 registrations across 1 African market— 11 active

Markets with RIFAXIMIN 200 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Refixana 200 mg
Film Coated Tablets
🇪🇬EgyptP and C Labs - Pellets and CR Productsactive
Dufaximin 200 mg
Film Coated Tablets
🇪🇬EgyptAUG Pharmaactive
Gutrifa 200mg
Film Coated Tablets
🇪🇬EgyptAdvanced Biopharmaceutical Company-Egyptactive
Trencedia 200 mg
Film Coated Tablets
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive
Refixana 200 mg
Film Coated Tablets
🇪🇬EgyptP and C Labs - Pellets and CR Productsactive
Gutrifa 200mg
Film Coated Tablets
🇪🇬EgyptAdvanced Biopharmaceutical Company-Egyptactive
Oxorifax 200 mg
Film Coated Tablets
🇪🇬EgyptInternational advanced pharmaceutical industries (INAD pharma)active
traviguard
Film Coated Tablets
🇪🇬EgyptTrend Pharm for Pharmaceuticalsactive
Rifaxerose 200mg
Film Coated Tablets
🇪🇬EgyptAVERROES PHARMA for pharmaceutical industriesactive
Dufaximin 200 mg
Film Coated Tablets
🇪🇬EgyptAUG Pharmaactive
Oxorifax 200 mg
Film Coated Tablets
🇪🇬EgyptInternational advanced pharmaceutical industries (INAD pharma)active

RIFAXIMIN 200 Mg ; in Africa — Regulatory Overview

RIFAXIMIN 200 Mg ; is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.